Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01931904 · ClinicalTrials.gov registry record
Eye Pressure Lowering Surgery
A clinical trial of Glaucoma, sponsored by Oregon Health and Science University.
- Recruiting
- Registry status
- 46
- Enrollment target
- 1
- Study location
NCT01931904: Recruiting study of Glaucoma, sponsored by Oregon Health and Science University.
NCT01931904 is a study of Glaucoma that is actively recruiting participants, run by Oregon Health and Science University. The registered enrollment target is 46 participants, below the 910-participant average among 92 other Glaucoma trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01931904, a study of Glaucoma, is actively recruiting participants, sponsored by Oregon Health and Science University.
- RECRUITING
- Registry status
- 46 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if lowering the pressure inside the eye improves blood flow to the eye.
Primary Outcome
To determine if IOP reduction improves ocular perfusion. Change in IOP reduction will be measured in mmHg.
Conditions Studied
Study Locations (1)
Oregon
- OHSU - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2014-02-01 |
| Est. Completion | 2026-05 |
What NCT01931904 shows while recruiting
NCT01931904 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 46 participants, a relatively small participant target, below the 910-participant average among 92 other Glaucoma trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Glaucoma appearing as the primary indexed condition, and to 0 interventions.
NCT01931904 reports a single indexed study location in Oregon.
Frequently Asked Questions
What is clinical trial NCT01931904 about?
NCT01931904 is a clinical study titled "Eye Pressure Lowering Surgery". The purpose of this study is to determine if lowering the pressure inside the eye improves blood flow to the eye.
What is the current status of trial NCT01931904?
This trial is currently recruiting. The enrollment target is 46 participants. The study started on 2014-02-01. Estimated completion is 2026-05.
What conditions does trial NCT01931904 study?
This clinical trial studies the following conditions: Glaucoma.
Who is sponsoring clinical trial NCT01931904?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01931904 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Glaucoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01931904's enrollment target sits among peer trials
46 69th of 92 higher than 24 of 92 other Glaucoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Glaucoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Functional and Structural Imaging for Glaucoma
RECRUITING
-
Topical Insulin for Glaucoma
RECRUITING · Phase 1
-
Village-Integrated Eye Worker Trial II
RECRUITING · NA
-
Phase 2 Study of BL1107 Eye Drops vs. Timolol in Adults With Primary Open Angle Glaucoma or Ocular Hypertension
RECRUITING · Phase 2
-
Tolerability of an Anesthesia-free Tonometer Tip
RECRUITING · NA
-
24-hour Wear Performance and Safety Study of Smartlens miLens Contact Lens for IOP Monitoring
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01890590 · 46 participants · NA
A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
- NCT03191149 · 46 participants · Phase 2
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
- NCT03510208 · 46 participants · Phase 1
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
- NCT04048278 · 46 participants · Early Phase 1
Lidocaine Infusion in Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI